Clinical and Translational Discovery (Dec 2022)
Metabolic reprogramming profile may inform prognosis and treatment protocols in acute promyelocytic leukaemia
Abstract
No abstracts available.Keywords
Clinical and Translational Discovery (Dec 2022)